Recent filings

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 9,766 shares - March 15, 2023

Accelerate Diagnostics, Inc.'s Chief Financial Officer just picked up 4,730 shares - March 15, 2023

Accelerate Diagnostics, Inc. director just picked up 55,282 shares - March 9, 2023

Accelerate Diagnostics, Inc.'s Chief Technology Officer just picked up 82,928 shares - March 6, 2023

Accelerate Diagnostics, Inc. director just picked up 50,886 shares - March 6, 2023

Accelerate Diagnostics, Inc. Just Filed Its Quarterly Report: Loss Per ShareBasic ... - March 3, 2023

Accelerate Diagnostics, Inc. Just Filed Its Quarterly Report: Loss Per ShareBasic ... - March 3, 2023

Accelerate Diagnostics, Inc. Just Filed Its Quarterly Report: Loss Per ShareBasic ... - March 3, 2023

Departure of Directors or Certain - Feb. 24, 2023

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 8,615 shares - Feb. 15, 2023

Accelerate Diagnostics, Inc.'s Chief Technology Officer was just granted 116,329 restricted shares - Feb. 15, 2023

Accelerate Diagnostics, Inc.'s Chief Financial Officer just picked up 4,616 shares - Feb. 15, 2023

On February  - Feb. 9, 2023

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 10,000 shares - Feb. 1, 2023

Accelerate Diagnostics, Inc.'s Chief Financial Officer just picked up 4,709 shares - Jan. 17, 2023

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 8,808 shares - Jan. 17, 2023

As previously - Jan. 13, 2023

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Jan. 11, 2023

Departure of Directors or Certain - Dec. 13, 2022

Accelerate Diagnostics Reports Third Quarter 2022 Financial Results - Nov. 15, 2022

Accelerate Diagnostics, Inc. Just Filed Its Quarterly Report: Loss Per ShareBasic ... - Nov. 14, 2022

On October - Oct. 21, 2022

As previously - Oct. 3, 2022

Accelerate Diagnostics, Inc.'s Chief Technology Officer just picked up 50,000 shares - Aug. 30, 2022

Accelerate Diagnostics Announces Proposed Public Offering Of Common Stock - Aug. 23, 2022

Accelerate Diagnostics, Inc.'s Chief Technology Officer just picked up 51,749 shares - Aug. 22, 2022

Prospectus [Rule 424(b)(5)] - Aug. 22, 2022

Accelerate Diagnostics, Inc.'s Chief Financial Officer just picked up 5,000 shares - Aug. 22, 2022

Major owner of Accelerate Diagnostics, Inc. just declared owning 18,792,022 shares of Accelerate Diagnostics, Inc. - Aug. 16, 2022

Accelerate Diagnostics, Inc. Just Filed Its Quarterly Report: Loss Per ShareBasic ... - Aug. 15, 2022

Accelerate Diagnostics Reports Second Quarter 2022 Financial Results - Aug. 15, 2022

Accelerate Diagnostics, Inc.'s Chief Technology Officer just declared owning 331,662 shares of Accelerate Diagnostics, Inc. - July 13, 2022

As previously - June 30, 2022

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 33,962 shares - June 24, 2022

Major owner of Accelerate Diagnostics, Inc. just declared owning 18,792,022 shares of Accelerate Diagnostics, Inc. - June 22, 2022

Accelerate Diagnostics, Inc. director was just granted 140,059 restricted shares - June 2, 2022

Accelerate Diagnostics, Inc. director was just granted 75,949 restricted shares - June 2, 2022

Accelerate Diagnostics, Inc. director was just granted 75,949 restricted shares - June 2, 2022

Accelerate Diagnostics, Inc. director was just granted 75,949 restricted shares - June 2, 2022

Major owner of Accelerate Diagnostics, Inc. was just granted 75,949 restricted shares - June 2, 2022

Accelerate Diagnostics, Inc. director was just granted 75,949 restricted shares - June 2, 2022

Accelerate Diagnostics, Inc. director was just granted 75,949 restricted shares - June 2, 2022

Major owner of Accelerate Diagnostics, Inc. was just granted 75,949 restricted shares - June 2, 2022

Accelerate Diagnostics, Inc. director was just granted 75,949 restricted shares - June 2, 2022

Accelerate Diagnostics, Inc. director was just granted 75,949 restricted shares - June 2, 2022

Specialized disclosure report - May 27, 2022

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 20, 2022

Securities to be offered to employees in employee benefit plans - May 20, 2022

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 20, 2022

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 20, 2022

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 20, 2022

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 20, 2022

Securities to be offered to employees in employee benefit plans, post-effective amendments - May 20, 2022

Material Modification to Rights of Security - May 17, 2022

Accelerate Diagnostics Reports First Quarter 2022 Financial Results - May 16, 2022

Accelerate Diagnostics, Inc. Just Filed Its Quarterly Report: Loss Per ShareBasic ... - May 16, 2022

Accelerate Diagnostics, Inc.'s Chief Financial Officer just picked up 27,821 shares - April 28, 2022

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 84,688 shares - April 28, 2022

Accelerate Diagnostics, Inc.'s Head of Commercial Operations just picked up 25,683 shares - April 25, 2022

Accelerate Diagnostics: (Name Of Registrant As Specified In Its Charter) - April 22, 2022

Accelerate Diagnostics, Inc. releases salary data. CEO sees compensation fall -25% - April 7, 2022

Notice of Exempt Offering of Securities, item 06b - April 7, 2022

Accelerate Diagnostics, Inc.'s Chief Financial Officer was just granted 190,299 restricted shares - April 6, 2022

Accelerate Diagnostics, Inc.'s Chief Executive Officer was just granted 888,060 restricted shares - April 6, 2022

Accelerate Diagnostics, Inc.'s Head of Commercial Operations was just granted 40,755 restricted shares - March 30, 2022

Accelerate Diagnostics, Inc.'s Chief Executive Officer was just granted 168,396 restricted shares - March 30, 2022

Accelerate Diagnostics, Inc.'s Chief Financial Officer was just granted 57,736 restricted shares - March 30, 2022

Other preliminary proxy statements - March 25, 2022

Entry into a Material Definitive - March 25, 2022

Entry into a Material Definitive - March 21, 2022

Accelerate Diagnostics, Inc. Just Filed Its Annual Report: Loss Per ShareBasic ... - March 14, 2022

Accelerate Diagnostics Reports Fourth Quarter And Full-Year 2021 Financial Results - March 8, 2022

Oracle Investment Management, Inc. just provided an update on share ownership of Accelerate Diagnostics, Inc. - Feb. 24, 2022

Oracle Investment Management, Inc. just provided an update on share ownership of Accelerate Diagnostics, Inc. - Feb. 11, 2022

Accelerate Diagnostics, Inc. director just declared 0 ownership of the company. - Feb. 8, 2022

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 6,347 shares - Feb. 7, 2022

Departure of Directors or Certain - Feb. 3, 2022

Registration statement under Securities Act of 1933 - Feb. 3, 2022

Accelerate Diagnostics, Inc. director just picked up 20,000 shares - Feb. 1, 2022

Major owner of Accelerate Diagnostics, Inc. just picked up 41,912 shares - Jan. 20, 2022

Major owner of Accelerate Diagnostics, Inc. just picked up 131,219 shares - Jan. 18, 2022

Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results - Jan. 13, 2022

Major owner of Accelerate Diagnostics, Inc. just picked up 45,226 shares - Jan. 12, 2022

Major owner of Accelerate Diagnostics, Inc. just picked up 10,000 shares - Jan. 6, 2022

Major owner of Accelerate Diagnostics, Inc. just picked up 997 shares - Jan. 4, 2022

Major owner of Accelerate Diagnostics, Inc. just picked up 57,062 shares - Dec. 30, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 54,541 shares - Dec. 22, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 74,127 shares - Dec. 21, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 20,000 shares - Dec. 20, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 17,050 shares - Dec. 17, 2021

Accelerate Diagnostics, Inc. director just picked up 13,022 shares - Dec. 10, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 21,702 shares - Dec. 10, 2021

Accelerate Diagnostics, Inc. director just picked up 19,531 shares - Dec. 10, 2021

Accelerate Diagnostics, Inc. director just picked up 8,681 shares - Dec. 10, 2021

Accelerate Diagnostics, Inc.'s Chief Executive Officer just picked up 4,340 shares - Dec. 10, 2021

Jack W. Schuler Living Trust just provided an update on activist position in Accelerate Diagnostics, Inc. - Dec. 3, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 1,000,000 shares - Nov. 30, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 48,987 shares - Nov. 24, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 56,850 shares - Nov. 23, 2021

Major owner of Accelerate Diagnostics, Inc. just picked up 116,444 shares - Nov. 22, 2021

Sorry, no schedule available for this company

Accelerate Diagnostics, Inc. (AXDX) Q3 2022 Earnings Call Transcript - Nov. 15, 2022

Accelerate Diagnostics Reports Third Quarter 2022 Financial Results - Nov. 14, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX - Nov. 14, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX - Nov. 4, 2022

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors - Oct. 27, 2022

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors - Oct. 26, 2022

The Law Offices of Frank R. Cruz Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors - Oct. 26, 2022

ACCELERATE DIAGNOSTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Accelerate Diagnostics, Inc. on Behalf of Accelerate Diagnostics Stockholders and Encourages Investors to Contact the Firm - Oct. 25, 2022

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the Firm - Oct. 25, 2022

Accelerate Diagnostics scheduled call to review 2022 third quarter results - Oct. 24, 2022

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the Firm - Oct. 24, 2022

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Accelerate Diagnostics, Inc. Investors to Inquire About Securities Class Action Investigation – AXDX - Oct. 24, 2022

Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock - Aug. 18, 2022

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock - Aug. 17, 2022

Accelerate Diagnostics Reports Second Quarter 2022 Financial Results - Aug. 15, 2022

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial Results - March 8, 2022

Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year results - Feb. 24, 2022

Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time - Feb. 2, 2022

Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results - Jan. 13, 2022

Accelerate Diagnostics to Participate Virtually in 40th Annual J. P. Morgan Healthcare Conference on January 13, 2022 - Dec. 29, 2021